Brain Iron Accumulation in Chronic Migraine: Pathophysiological Insights and Imaging Biomarkers for Personalized Therapy
Acta Neurologica Scandinavica · 2026-01 · 2026 (1)
DOI: 10.1155/ane/1977026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 06.07.2026. Verfasst von Shoji Kikui und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Aim Chronic migraine (CM) is a disabling neurological disorder characterized by persistent alterations in central pain modulation pathways. Emerging evidence suggests that abnormal iron accumulation in deep brain nuclei, particularly the periaqueductal gray (PAG), may represent a potential pathophysiological mechanism and an imaging biomarker of disease progression. This review is aimed at synthesizing current knowledge on brain iron metabolism in migraine and its clinical relevance.
Methods
We narratively reviewed the literature on conventional and advanced magnetic resonance imaging (MRI) techniques, including T2‐weighted imaging, susceptibility‐weighted imaging, and quantitative susceptibility mapping (QSM), and analyzed their findings regarding iron deposition in patients with migraine, especially CM.
Results
Multiple studies have demonstrated increased iron accumulation in the PAG, red nucleus, and nucleus accumbens in CM, correlating with disease duration, medication overuse, and poor treatment responsiveness. QSM has emerged as a sensitive method for quantifying regional iron loads. Three hypotheses have been proposed: iron accumulation as a consequence of repeated attacks, as a causal factor in chronification, or as a comorbid process linked to shared risk factors. Brain iron burden may be associated with therapeutic response to onabotulinumtoxinA and calcitonin gene‐related peptide‐targeted therapies.
Discussion
At the molecular level, iron‐mediated oxidative damage through ferritinophagy and ferroptosis may contribute to neuronal dysfunction in pain modulatory circuits. While inconsistencies exist across studies, converging evidence supports the importance of iron dysregulation in migraine chronification.
Conclusion
Brain iron accumulation may represent a promising imaging biomarker and potential therapeutic target in CM. Further longitudinal and mechanistic studies are warranted to clarify its causal role and to validate iron‐based metrics for personalized treatment strategies.
Zitieren
APA
Kikui, S., Danno, D., & Takeshima, T. (2026). Brain Iron Accumulation in Chronic Migraine: Pathophysiological Insights and Imaging Biomarkers for Personalized Therapy. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/1977026
Vancouver
Kikui S, Danno D, Takeshima T. Brain Iron Accumulation in Chronic Migraine: Pathophysiological Insights and Imaging Biomarkers for Personalized Therapy. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/1977026
BibTeX
@article{Kikui2026,
author = {Kikui, Shoji and Danno, Daisuke and Takeshima, Takao},
title = {Brain Iron Accumulation in Chronic Migraine: Pathophysiological Insights and Imaging Biomarkers for Personalized Therapy},
journal = {Acta Neurologica Scandinavica},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ane/1977026}
}
EUVIMED